Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II

CM. Linde, C. Normand, N. Bogale, A. Auricchio, M. Sterlinski, G. Marinskis, C. Sticherling, A. Bulava, ÓC. Pérez, AH. Maass, KK. Witte, R. Rekvava, S. Abdelali, K. Dickstein,

. 2018 ; 20 (10) : 1457-1468. [pub] 20180620

Language English Country England, Great Britain

Document type Comparative Study, Journal Article, Multicenter Study

Persistent link   https://www.medvik.cz/link/bmc19012647

BACKGROUND: To date, there are no data from randomized controlled studies on the benefit of cardiac resynchronization therapy (CRT) when implanted as an upgrade in patients with a previous device as compared to de novo CRT. In the CRT Survey II we compared the baseline data of patients upgraded to CRT (CRT-P/CRT-D) from a previous pacemaker (PM) or implantable cardioverter-defibrillator (ICD) to de novo CRT implantation. METHODS AND RESULTS: In the European CRT Survey II, clinical practice data of patients undergoing CRT and/or ICD implantation across 42 European Society of Cardiology (ESC) countries were collected between October 2015 and December 2016. Out of a total of 11 088 patients, 2396 (23.2%) were upgraded from a previous PM or ICD and 7933 (76.8%) underwent de novo implantation. Compared to de novo implantations, upgraded patients were older, more often male, more frequently had ischaemic heart failure aetiology, atrial fibrillation, reduced renal function, worse heart failure symptoms, and higher N-terminal pro-B-type natriuretic peptide levels. Upgraded patients were more often PM-dependent and less frequently received CRT-D. Total peri-procedural, in-hospital complications and length of hospital stay were similar. Upgraded patients were less frequently treated with heart failure medication at discharge. CONCLUSION: Despite a lack of evidenced-based data, close to one quarter of all CRT implantations across 42 ESC countries were upgrades from a previous PM or ICD. Despite older age and worse symptoms, the CRT implantation procedures in upgraded patients were equally frequently successful and complications similar to de novo implantations. These results call for more studies.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19012647
003      
CZ-PrNML
005      
20190411113939.0
007      
ta
008      
190405s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1002/ejhf.1235 $2 doi
035    __
$a (PubMed)29806208
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Linde, Cecilia M $u Heart and Vascular Theme, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
245    10
$a Upgrades from a previous device compared to de novo cardiac resynchronization therapy in the European Society of Cardiology CRT Survey II / $c CM. Linde, C. Normand, N. Bogale, A. Auricchio, M. Sterlinski, G. Marinskis, C. Sticherling, A. Bulava, ÓC. Pérez, AH. Maass, KK. Witte, R. Rekvava, S. Abdelali, K. Dickstein,
520    9_
$a BACKGROUND: To date, there are no data from randomized controlled studies on the benefit of cardiac resynchronization therapy (CRT) when implanted as an upgrade in patients with a previous device as compared to de novo CRT. In the CRT Survey II we compared the baseline data of patients upgraded to CRT (CRT-P/CRT-D) from a previous pacemaker (PM) or implantable cardioverter-defibrillator (ICD) to de novo CRT implantation. METHODS AND RESULTS: In the European CRT Survey II, clinical practice data of patients undergoing CRT and/or ICD implantation across 42 European Society of Cardiology (ESC) countries were collected between October 2015 and December 2016. Out of a total of 11 088 patients, 2396 (23.2%) were upgraded from a previous PM or ICD and 7933 (76.8%) underwent de novo implantation. Compared to de novo implantations, upgraded patients were older, more often male, more frequently had ischaemic heart failure aetiology, atrial fibrillation, reduced renal function, worse heart failure symptoms, and higher N-terminal pro-B-type natriuretic peptide levels. Upgraded patients were more often PM-dependent and less frequently received CRT-D. Total peri-procedural, in-hospital complications and length of hospital stay were similar. Upgraded patients were less frequently treated with heart failure medication at discharge. CONCLUSION: Despite a lack of evidenced-based data, close to one quarter of all CRT implantations across 42 ESC countries were upgrades from a previous PM or ICD. Despite older age and worse symptoms, the CRT implantation procedures in upgraded patients were equally frequently successful and complications similar to de novo implantations. These results call for more studies.
650    _2
$a senioři $7 D000368
650    _2
$a prostředky srdeční resynchronizační terapie $x statistika a číselné údaje $7 D058409
650    12
$a kardiologie $7 D002309
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a srdeční selhání $x epidemiologie $x terapie $7 D006333
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prevalence $7 D015995
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a rizikové faktory $7 D012307
650    12
$a společnosti lékařské $7 D012955
650    12
$a průzkumy a dotazníky $7 D011795
650    _2
$a míra přežití $x trendy $7 D015996
650    _2
$a výsledek terapie $7 D016896
651    _2
$a Evropa $x epidemiologie $7 D005060
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Normand, Camilla $u Department of Internal Medicine, University of Bergen, Bergen, Norway. Department of Cardiology, Stavanger, Norway.
700    1_
$a Bogale, Nigussie $u Department of Cardiology, Stavanger, Norway.
700    1_
$a Auricchio, Angelo $u Clinical Electrophysiology Unit, Fondazione Cardiocentro Ticino, Lugano, Switzerland; and University Magdeburg, Germany.
700    1_
$a Sterlinski, Maciej $u Heart Rhythm Department, Institute of Cardiology, Warsaw, Poland.
700    1_
$a Marinskis, Germanas $u Clinic of Heart Diseases, Vilnius University, Lithuania.
700    1_
$a Sticherling, Christian $u University Hospital, Basel, Switzerland.
700    1_
$a Bulava, Alan $u Faculty of Health and Social Sciences, University of South Bohemia, Ceske Budejovice, Czech Republic.
700    1_
$a Pérez, Óscar Cano $u Unidad de Arritmias, Hospital Universitari I Politècnic La Fe, Valencia, Spain.
700    1_
$a Maass, Alexander H $u University of Groningen, Department of Cardiology, University Medical Center Groningen, Groningen, The Netherlands.
700    1_
$a Witte, Klaus K $u University of Leeds, Leeds, UK.
700    1_
$a Rekvava, Roin $u Research Institute of Cardiology and Internal Diseases, Almaty, Kazakhstan.
700    1_
$a Abdelali, Salima $u Clinique Belvedere, Rabat, Morocco.
700    1_
$a Dickstein, Kenneth $u Department of Internal Medicine, University of Bergen, Bergen, Norway. Department of Cardiology, Stavanger, Norway.
773    0_
$w MED00006634 $t European journal of heart failure $x 1879-0844 $g Roč. 20, č. 10 (2018), s. 1457-1468
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29806208 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190405 $b ABA008
991    __
$a 20190411113956 $b ABA008
999    __
$a ok $b bmc $g 1391957 $s 1050952
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 20 $c 10 $d 1457-1468 $e 20180620 $i 1879-0844 $m European journal of heart failure $n Eur J Heart Fail $x MED00006634
LZP    __
$a Pubmed-20190405
Back

Find record

Citation metrics

Logged in users only

Archiving options